Retour
Également cotée sous
LTGHY
OTC
Fourchette du Jour
0,68 €
0,72 €
Fourchette 52 Semaines
0,68 €
0,82 €
Volume
87
Moyenne 50J / 200J
0,73 €
/
0,78 €
Clôture Précédente
0,68 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 4,4 | 0,4 |
| P/B | 1,5 | 2,9 |
| ROE % | 3,4 | 3,7 |
| Net Margin % | 15,4 | 3,9 |
| Rev Growth 5Y % | -51,9 | 10,0 |
| D/E | 6,0 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2028 |
1,63 €
1,61 € – 1,68 €
|
29 B | 1 |
| FY2027 |
1,51 €
1,49 € – 1,56 €
|
28 B | 1 |
| FY2026 |
1,33 €
1,32 € – 1,37 €
|
26 B | 1 |
Points Clés
Revenue declined -51,86% annually over 5 years
Earnings declined -95,40% over the past year
ROE of 3,37% is below average
Net margin of 15,39% shows strong profitability
Debt/Equity of 6,04 — high leverage
Generating 138,29M in free cash flow
Croissance
Revenue Growth (5Y)
-51,86%
Revenue (1Y)-94,34%
Earnings (1Y)-95,40%
FCF Growth (3Y)-3,77%
Qualité
Return on Equity
3,37%
ROIC2,06%
Net Margin15,39%
Op. Margin8,77%
Sécurité
Debt / Equity
6,04
Current Ratio0,07
Interest Coverage6,38
Valorisation
P/E Ratio
4,40
P/B Ratio1,50
EV/EBITDA37,22
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -94,34% | Revenue Growth (3Y) | -74,89% |
| Earnings Growth (1Y) | -95,40% | Earnings Growth (3Y) | -8,26% |
| Revenue Growth (5Y) | -51,86% | Earnings Growth (5Y) | -40,34% |
| Profitability | |||
| Revenue (TTM) | 1,44B | Net Income (TTM) | 222,18M |
| ROE | 3,37% | ROA | 15,04% |
| Gross Margin | 23,29% | Operating Margin | 8,77% |
| Net Margin | 15,39% | Free Cash Flow (TTM) | 138,29M |
| ROIC | 2,06% | FCF Growth (3Y) | -3,77% |
| Safety | |||
| Debt / Equity | 6,04 | Current Ratio | 0,07 |
| Interest Coverage | 6,38 | Dividend Yield | 0,02% |
| Valuation | |||
| P/E Ratio | 4,40 | P/B Ratio | 1,50 |
| P/S Ratio | 0,68 | PEG Ratio | -0,92 |
| EV/EBITDA | 37,22 | Dividend Yield | 0,02% |
| Market Cap | 978,68M | Enterprise Value | 4,71B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,44B | 25,52B | 22,89B | 28,21B | 26,89B |
| Net Income | 222,18M | 4,83B | 264,00M | 1,53B | 1,75B |
| EPS (Diluted) | 0,15 | 3,26 | 0,18 | 1,05 | 1,14 |
| Gross Profit | 336,20M | 17,81B | 6,48B | 5,87B | 18,35B |
| Operating Income | 126,56M | 2,90B | 2,44B | 2,76B | 3,01B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,48B | 24,34B | 45,62B | 42,24B | 40,78B |
| Total Liabilities | 779,01M | 10,83B | 24,33B | 22,38B | 21,61B |
| Shareholders' Equity | 654,18M | 12,54B | 20,21B | 18,75B | 18,07B |
| Total Debt | 3,95B | 4,42B | 13,19B | 13,69B | 12,55B |
| Cash & Equivalents | 219,08M | 2,46B | 846,00M | 2,80B | 2,67B |
| Current Assets | 486,74M | 7,54B | 29,41B | 7,78B | 7,41B |
| Current Liabilities | 7,05B | 5,27B | 11,20B | 7,65B | 7,39B |